Positive for pms2+ (increase of 2 at post meiotic segregation), which means that there is a defect in the gene, is a form of genetic testing that can diagnose the disease, guide the use of medication, predict the risk of the disease as well as formulate a treatment plan.
1. Diagnose the disease: Through genetic testing, it can detect the cancer-causing sites in the body of colon cancer patients, that is, the mutated genes that cause the disease.
2. Guiding the use of drugs: finding the relevant disease-causing genes can be used to guide specialists in choosing chemotherapeutic drugs, which can help reduce the toxic side effects of drugs.
3. Predicting the risk of disease: Through genetic testing, patients can be detected whether they have mutated genes for familial precancerous colon cancer, and the risk of disease can also be predicted.
4. Formulate treatment plan: Specific treatment plan can be formulated according to the relevant genetic test results, so as to facilitate the patients to guide the treatment in targeted therapy and chemotherapy or predict the risk of colon cancer.
In addition, colon cancer is very dangerous, and once diagnosed, it is necessary to actively seek treatment.